Contineum Therapeutics In...

NASDAQ: CTNM · Real-Time Price · USD
8.14
0.76 (10.30%)
At close: Aug 18, 2025, 3:59 PM
8.26
1.41%
After-hours: Aug 18, 2025, 04:57 PM EDT

Contineum Therapeutics Class A Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-42.26M 22.72M -24.25M -29M
Depreciation & Amortization
258K 195K 329K 325K
Stock-Based Compensation
6.8M 2.22M 1.93M 1.75M
Other Working Capital
4.19M -1.02M -1.04M 218K
Other Non-Cash Items
-2.98M -4.76M 5.96M 164K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
5.33M -1.02M -1.27M 108K
Operating Cash Flow
-32.84M 19.35M -20.12M -26.27M
Capital Expenditures
-514K -414K -118K -168K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-226.41M -141.87M -64.7M -66.78M
Sales Maturities Of Investments
157.16M 76.71M 87.12M 1.98M
Other Investing Acitivies
20K n/a 22.42M -64.8M
Investing Cash Flow
-69.74M -65.57M 22.3M -64.97M
Debt Repayment
n/a -3.75M -1.25M n/a
Common Stock Repurchased
n/a -28K -4K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
790K -184K 15K 113K
Financial Cash Flow
109M 56.18M -1.24M 79.84M
Net Cash Flow
6.42M 9.96M 939K -11.39M
Free Cash Flow
-33.36M 18.93M -20.24M -26.43M